CAGE Bio Inc., is excited to announce the execution of a license agreement with TAGCyx, and PeptiStar for development and commercialization of TAGX-0003 for the Treatment of Immunodermatology Diseases Mediated by the IFN-Gamma Pathway.
https://t.co/SJACoJvIwj
Say goodbye to #dryhands! The perfect stocking stuffer (and ALL YEAR gift!). #10 on Amazon's Hot New Releases list. ionSURE - get yours today and save 15% through the end of the year :)
https://t.co/PpsGPaS7SQ
IonSURE (Waterless Moisturizing Hand Wash) has officially been launched. Thank you all for your support, we’re looking forward to a successful 2022! Stay tuned for more.
https://t.co/SKnTWAPsB3
Suffering from moderate to severe papulopustular facial rosacea? Check out this clinical trial to try an investigational product that may help. They are currently enrolling rosacea patients. There is more info at https://t.co/pOnyZPZzFc if you’re interested!
We just announced dosing of the first patient in our Phase 2 clinical trial for the treatment of inflammatory lesions of rosacea. Read more: https://t.co/ZCzBQELFSb
We just announced the closing of a $7.2 million over-subscribed Series A financing led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
https://t.co/ZCzBQELFSb
Our paper with @rahmioklu out today in @ScienceTM on using an ionic liquid agent LATTE for treating large hepatocellular tumors to help bridge more patients to liver transplantation https://t.co/988gWLuKw0 @MayoClinic@hseas@wyssinstitute@EdenTanner
Mayo Clinic-developed ionic liquid shows promise in treating #LiverCancer, according to new, preclinical research. This liquid helps distribute chemotherapy drugs more uniformly into liver tumors, providing a more targeted therapy. @rahmioklu@SMitragotri https://t.co/KT6yJqYSa8
Ionic liquid could solve a problem that has long plagued drug delivery to tumors and provide new hope to patients with liver cancer awaiting a liver transplant: https://t.co/f1P13bxQ83 @SMitragotri@wyssinstitute@rahmioklu@MayoClinic@ScienceTM
New episode of the Innovate Fort Worth podcast is out! This one features Nitin Joshi, the co-founder and CEO of @CageBioInc who just moved their operations to Fort Worth from Silicon Valley.
https://t.co/mc8iZerCr0
#innovation#FortWorth#podcasts
CAGE Bio is focused on discovering, developing, and commercializing transformative therapies to treat dermatological conditions. Learn more about our ionic liquid technology and its potential to improve drug delivery from our Co-Founder @SMitragotri
https://t.co/NCNxaETR9d
Once voted the ‘British innovation most likely to shape the 21st century’ in a nationwide poll, ionic liquids are an intriguing approach to chemical solvents
https://t.co/UpfiZOe6UK
Check out the latest publication in BioTM @BioTM_Buzz on clinical translation of ionic liquid cage for rosacea. Seven steps of translation: scale-up, cmc, storage stability, mechanism of action, dose-dependence, glp-toxicity, and clinical study @CageBioInc https://t.co/JYt2TMFAJs
We are thrilled to announce the publication of successful clinical translation and an open‐label phase 1b cosmetic study of CGB400 in @BioTM. https://t.co/z2qpzVK1oY